TaurelFinance, decoded

Live

Loading market data…

Mendus narrows Q2 loss as blood cancer trials advance

Investing.com· Investing.com· Aug 20, 2026 · 6:12 AM

Mendus narrows Q2 loss as blood cancer trials advance

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Russia stocks lower at close of trade; MOEX Russia Index down 1.93%

stocksabout 1 hour ago

Russia stocks lower at close of trade; MOEX Russia Index down 1.93%

Investing.com

Fitch cuts Flowers Foods rating to ’BB+’ on volume pressures

stocksabout 1 hour ago

Fitch cuts Flowers Foods rating to ’BB+’ on volume pressures

Investing.com

Fitch downgrades PG&E outlook on wildfire liability concerns

stocksabout 1 hour ago

Fitch downgrades PG&E outlook on wildfire liability concerns

Investing.com